Volume | 8,786,506 |
|
|||||
News | - | ||||||
Day High | 73.613 | Low High |
|||||
Day Low | 72.64 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Boston Scientific Corporation | BSX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
72.88 | 72.64 | 73.613 | 73.17 | 73.26 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
70,658 | 8,786,506 | US$ 73.21 | US$ 643,219,317 | - | 48.35 - 74.39 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:51:05 | 2 | US$ 72.50 | USD |
Boston Scientific (BSX) Options Flow Summary
Boston Scientific Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
107.35B | 1.47B | - | 14.35B | 1.57B | 1.07 | 68.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Boston Scientific News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BSX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 67.87 | 74.39 | 66.80 | 70.60 | 9,422,823 | 5.13 | 7.56% |
1 Month | 68.42 | 74.39 | 66.80 | 69.06 | 6,515,874 | 4.58 | 6.69% |
3 Months | 65.00 | 74.39 | 64.08 | 67.33 | 6,308,323 | 8.00 | 12.31% |
6 Months | 50.75 | 74.39 | 49.145 | 61.19 | 6,586,914 | 22.25 | 43.84% |
1 Year | 52.31 | 74.39 | 48.35 | 56.25 | 7,368,474 | 20.69 | 39.55% |
3 Years | 42.81 | 74.39 | 34.98 | 47.40 | 7,533,815 | 30.19 | 70.52% |
5 Years | 37.17 | 74.39 | 24.10 | 43.08 | 8,211,633 | 35.83 | 96.39% |
Boston Scientific Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. |